Back to School: How biopharma can reboot drug development. Access exclusive analysis here
NOVC began a placebo-controlled Phase II trial in 132 patients with advanced pancreatic adenocarcinoma
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury